Capital Flow Monitor · Sponsors · CIK 1796304
OrbiMed Genesis Fund, L.P.
C/O ORBIMED GENESIS GP LLC, NEW YORK, NY, 10022 · (212) 739-6400
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$353.3M
% sold
—
Investors
107
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | D/A ·current | 506(b) | — | $353.3M | — | 107 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- - OrbiMed Genesis GP LLC — Executive Officer, New York, NY
-
- OrbiMed Advisors LLC — Executive Officer / Promoter, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, Ltd. $145.9M of —
-
Sven H. Borho — Executive Officer, New York, NY
5 other raises
- OrbiMed Partners, Ltd. $2.61B of —
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
- OrbiMed Genesis Fund, Ltd. $145.9M of —
-
Carl L. Gordon — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
W. Carter Neild — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
Geoffrey C. Hsu — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
C. Scotland Stevens — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
David P. Bonita — Executive Officer, New York, NY
1 other raise
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
Matthew S. Rizzo — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
-
Peter A. Thompson — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
- RECODE THERAPEUTICS, INC. $29.4M of $29.4M · 100.0%
-
Mona Ashiya — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Private Investments X, LP $1.67B of $1.75B · 95.4%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.